NLSP-Phase 2a Quilience Results Due, approx date

The results to this study are due by the end of September, so we will have this on the Calendar with a start and end date giving a 15 day window.

Often time, phase 2 study results can be pretty explosive, as they are both a rumor fueler and catalyst in and of themselves. Phase 2 is meant as a safety study, not efficacy as much, but eyes will be on efficacy data. Early results showed “best in-class efficiency.”

Event traders may be looking at this with greedy eyes, which would be one of the many reasons the Runup traders play it too. Nothing like getting in a month before a big event and riding the bullish price action from other people entering before the results. Runup Traders often would exit their position before the actual news is announced, capitalizing on the “rumor” period. Whereas, Event Traders may opt to buy and hold through, hoping to see better than anticipated efficacy results on top of great safety data.

Only time will tell! Runup traders should start monitoring the technicals 6-8 weeks in advance, looking for bullish reversal indications from the Williams %R, MACD, and Relative Volume